These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Relative HIV resistance in kenyan sex workers is not due to an altered prevalence or mucosal immune impact of herpes simplex virus type 2 infection. Baltzer H, Chege D, Rebbapragada A, Wachihi C, Shin LY, Kimani J, Ball TB, Jaoko W, Plummer FA, Kaul R. Curr HIV Res; 2009 Sep; 7(5):504-7. PubMed ID: 19925401 [Abstract] [Full Text] [Related]
23. Role of Interleukin 32 in Human Immunodeficiency Virus Reactivation and Its Link to Human Immunodeficiency Virus-Herpes Simplex Virus Coinfection. Mesquita PMM, Preston-Hurlburt P, Keller MJ, Vudattu N, Espinoza L, Altrich M, Anastos K, Herold KC, Herold BC. J Infect Dis; 2017 Feb 15; 215(4):614-622. PubMed ID: 28007920 [Abstract] [Full Text] [Related]
28. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Parr MB, Kepple L, McDermott MR, Drew MD, Bozzola JJ, Parr EL. Lab Invest; 1994 Mar 15; 70(3):369-80. PubMed ID: 8145530 [Abstract] [Full Text] [Related]
34. Pre-exposure prophylaxis differentially alters circulating and mucosal immune cell activation in herpes simplex virus type 2 seropositive women. Richert-Spuhler LE, Pattacini L, Plews M, Irungu E, Muwonge TR, Katabira E, Mugo N, Meyers AFA, Celum C, Baeten JM, Lingappa JR, Lund JM. AIDS; 2019 Nov 15; 33(14):2125-2136. PubMed ID: 31335802 [Abstract] [Full Text] [Related]
35. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada. Romanowski B, Myziuk LN, Walmsley SL, Trottier S, Singh AE, Houston S, Joffe M, Chiu I. Sex Transm Dis; 2009 Mar 15; 36(3):165-9. PubMed ID: 19098690 [Abstract] [Full Text] [Related]
36. Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2. Milligan GN. J Virol; 1999 Aug 15; 73(8):6380-6. PubMed ID: 10400730 [Abstract] [Full Text] [Related]
37. Herpes simplex virus type 2 coinfection does not accelerate CD4 count decline in untreated HIV infection. Tan DH, Raboud JM, Kaul R, Brunetta J, Kaushic C, Kovacs C, Lee E, Luetkehoelter J, Rachlis A, Smaill F, Smieja M, Walmsley SL. Clin Infect Dis; 2013 Aug 15; 57(3):448-57. PubMed ID: 23572481 [Abstract] [Full Text] [Related]
38. Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women. Mayaud P, Nagot N, Konaté I, Ouedraogo A, Weiss HA, Foulongne V, Defer MC, Sawadogo A, Segondy M, Van de Perre P, ANRS 1285 Study Group. Sex Transm Infect; 2008 Oct 15; 84(5):332-7. PubMed ID: 18596069 [Abstract] [Full Text] [Related]
39. The impact of pregnancy on anti-HIV activity of cervicovaginal secretions. Hughes BL, Dutt R, Raker C, Barthelemy M, Rossoll RM, Ramratnam B, Wira CR, Cu-Uvin S. Am J Obstet Gynecol; 2016 Dec 15; 215(6):748.e1-748.e12. PubMed ID: 27393267 [Abstract] [Full Text] [Related]